Please login to the form below
US backs Sanofi’s ‘fast-track’ coronavirus vaccine
Development will tap into earlier work on the SARS virus
BMS’ Opdivo combo misses the mark in pancreatic cancer
Failed to reach primary endpoint of progression-free survial
FDA sets June decision date for Tecentriq monotherapy in NSCLC
Aims for the first-line setting where Merck's Keytruda dominates
Pfizer’s Vyndaqel is first EU therapy for ATTR cardiomyopathy
EU approval will help drug achieve blockbuster status
UPDATED: J&J expands US partnership for coronavirus treatments
Expands on exisiting alliance announced last week
Ex-Sandoz exec admits role in generic drug price-fixing plot
Reignites criticism of high drug prices in the US
Merck’s Ebola vaccine wins approval in four African countries
Follows approvals in US and Europe last year
ReNeuron set for recovery after Woodford stake sale
Edison analyst says sale should help shares to stabilise
Servier and Oncodesign reach first milestone in Parkinson’s partnership
Oncodesign receives first success payment of €1m
Q&A: Stefi Rucci
PME interviews SAY Communications' joint MD and Director of Healthcare
-
Q&A: Emma SergeantPME interviews president of the DAS Group of Companies in Europe
-
Q&A: Vicky BramhamPME interviews OPEN Health Patient & Brand Communications' managing director, PR
-
Bayer shares dip as Novartis gets EU okay for Beovu in wet AMDNew drug due for launch in Europe in the second quarter
-
SMC enables access to Kyowa Kirin’s Crysvita for rare bone diseaseDrug is being reviewed under new ultra-orphan pathway
-
BMS unveils long-term results for Opdivo in kidney cancerResults include updated data for Opdivo with or without Yervoy
-
Roche’s PD-L1 inhibitor Tecentriq approved in China for SCLCSolidifies immunotherapy drug's dominance in the setting
-
After FDA refusal, Takeda builds case for subcutaneous EntyvioIntravenous Entyvio is already available in 60 countries
-
US states reject drug distributors’ opioid settlementThe Wall Street Journal reports at least 21 states want a larger settlement
-
Seattle Genetics wins FDA priority review for oral HER2 drugIf approved will compete with AZ/Daiichi Sankyo's Enhertu
Latest appointments
-
M Booth Health appoints Karen Strauss to lead strategy and innovationStrauss joins with expertise and experience gained at Ketchum
-
imc group appoints Amber Fensome to senior leadership position Fensome brings over 20 years’ experience to the role
-
New hires at Crescendo, Healx and Galecto The latest movers in pharma
-
Ex-Roche CMO Sandra Horning joins Gilead’s board of directorsHorning retired from Roche last August
-
PM Society announces new co-chairs for 2020 Caroline Benson and Colin Williams will succeed Craig Bradley
Featured jobs
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
-
Account Manager (PR)
-
Great Benefits
-
Account Manager
-
£Competitive Salary
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Experienced medical editor
-
Competitive salary and bonus scheme
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
- Client Services Director - Digital MedComms
-
£60000 - £80000 per annum, Benefits: Pension, healthcare, dedicated training budget, regul
- Senior Medical Writer, MedComms Agency
-
Salary TBC
-
Scientific Director
-
£60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more
-
Account Director, Medical Education
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Account Director, Healthcare Communications
-
Salary TBC
-
Senior External Communications Lead
-
£Competitive Salary
-
Account director
-
Competitive salary and bonus scheme
-
Publications director
-
Competitive salary and bonus scheme
-
Account Director
-
£Competitive Salary
Subscribe to our email news alerts
- Seattle Genetics wins FDA priority review for oral HER2 drug
- Merck chases Roche with triple-negative breast cancer data for Keytruda
- BMS unveils long-term results for Opdivo in kidney cancer
- Merck chases Roche with triple-negative breast cancer data for Keytruda
- J&J gets US backing for vaccine against coronavirus, christened Covid-19
- Novartis plans inclisiran trial in the UK
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- CSR 'Christmas Spirit' 2019
- OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...
- Interactive infographic
- Living With: The journey from the patient’s perspective...
- Article: Spotlight on Mexico
- Healthcare under AMLO – One year on...
Quick links
Infographics
